Randomized phase II trial of cyclophosphamide and the oral poly (ADP-ribose) polymerase inhibitor veliparib in patients with recurrent, advanced triple-negative breast cancer (Q36880037)
Jump to navigation
Jump to search
scientific article published on 21 March 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Randomized phase II trial of cyclophosphamide and the oral poly (ADP-ribose) polymerase inhibitor veliparib in patients with recurrent, advanced triple-negative breast cancer |
scientific article published on 21 March 2016 |
Statements
1 reference
Randomized phase II trial of cyclophosphamide and the oral poly (ADP-ribose) polymerase inhibitor veliparib in patients with recurrent, advanced triple-negative breast cancer (English)
1 reference
David R Gandara
1 reference
Shivaani Kummar
1 reference
James L Wade
1 reference
Amit M Oza
1 reference
Daniel Sullivan
1 reference
Alice P Chen
1 reference
Jiuping Ji
1 reference
Robert J Kinders
1 reference
Lihua Wang
1 reference
Deborah Allen
1 reference
Geraldine O'Sullivan Coyne
1 reference
Seth M Steinberg
1 reference
James H Doroshow
1 reference
21 March 2016
1 reference
1 reference
355-363
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference